• Explore /
  • Poster
  • / Genomic-based predictive biomarkers to anti-HER2 therapies: A combined analysis of CALGB 40601 (Alliance) and PAMELA clinical trials.

Genomic-based predictive biomarkers to anti-HER2 therapies: A combined analysis of CALGB 40601 (Alliance) and PAMELA clinical trials.

Abstract Poster

Authors

Aranzazu Fernandez-Martinez

Aranzazu Fernandez-Martinez

Lineberger Comprehensive Center. Department of Genetics. University of North Carolina, Chapel Hill, NC

Aranzazu Fernandez-Martinez , Maki Tanioka , Cheng Fan , Joel S. Parker , Katherine A. Hoadley , Ian E. Krop , Javier Cortes , Antonio Llombart Cussac , Paolo Nuciforo , Patricia Galván , Tomas Pascual , Ann H. Partridge , Aleix Prat , Lisa A. Carey , Charles M. Perou

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Neoadjuvant Therapy

Citation

J Clin Oncol 37, 2019 (suppl; abstr 571)

DOI

10.1200/JCO.2019.37.15_suppl.571

Abstract #

571

Poster Bd #

63

Abstract Disclosures

Similar Posters

First Author: Ning Liao

First Author: Elad Hikri

First Author: S. Loibl

First Author: Christian F. Singer